Third, due to limitations of our subgroup analysis that investigated whether the survival benefit differs by patient characteristics, including the presence of diabetes and patient age, and the lower statistical power in the interaction of age or diabetes status and Hb, one should be very cautious in determining Hb target according to patient characteristics. Here, GSTM1 is linked to diabetes mellitus.